Safety and Immunogenicity of Various Formulations of Live Attenuated Tetravalent Dengue Vaccine in Healthy US Adults

NCT00350337 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

86

Enrollment

FED

Sponsor class

Conditions

Dengue

Interventions

BIOLOGICAL: Pre-transfection F17
BIOLOGICAL: Post-transfection F17
BIOLOGICAL: Post-transfection F19
OTHER: Placebo

Sponsor

U.S. Army Medical Research and Development Command

Collaborators

[object Object]
[object Object]